Kenmerk
Anorexia
Lack of desire to eat (loss of appetite).
Samenvatting
- Ook bekend als
- Deliberately not eating, Obsessive dieting, Refusing to eat
- Lichaamssysteem
- Abnormality of the digestive system
ReferentiegenoomGRCh38hg38
Posities op gen- en variantpagina's volgen deze keuze, in deze browser.
Read the genes linked to Anorexia, and the rest of your genome, with one test.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken
Mijn Genome Test bestellen132 genen gekoppeld aan Anorexia
Veranderingen in deze genen veroorzaken zeldzame aandoeningen waarbij Anorexia voorkomt. De meeste mensen met dit kenmerk hebben geen van die aandoeningen, en een gen op deze lijst zegt niets over het eigen genoom van iemand.
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| ITPR3inositol 1,4,5-trisphosphate receptor type 3 | Altijd | In 1 aandoening |
| NFS1NFS1 cysteine desulfurase | Altijd | In 1 aandoening |
| PTCRApre T cell antigen receptor alpha | Altijd | In 1 aandoening |
| BANK1B cell scaffold protein with ankyrin repeats 1 | Heel vaak (80–99%) | In 1 aandoening |
| BLKBLK proto-oncogene, Src family tyrosine kinase | Heel vaak (80–99%) | In 1 aandoening |
| BRCA1BRCA1 DNA repair associated | Heel vaak (80–99%) | In 2 aandoeningen |
| BRCA2BRCA2 DNA repair associated | Heel vaak (80–99%) | In 2 aandoeningen |
| C4Acomplement C4A (Chido/Rodgers blood group) | Heel vaak (80–99%) | In 2 aandoeningen |
| C4Bcomplement C4B (Chido/Rodgers blood group) | Heel vaak (80–99%) | In 1 aandoening |
| CD4CD4 molecule | Heel vaak (80–99%) | In 1 aandoening |
| CDKN2Acyclin dependent kinase inhibitor 2A | Heel vaak (80–99%) | In 1 aandoening |
| CR2complement C3d receptor 2 | Heel vaak (80–99%) | In 1 aandoening |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Heel vaak (80–99%) | In 1 aandoening |
| DNASE1deoxyribonuclease 1 | Heel vaak (80–99%) | In 1 aandoening |
| ETS1ETS proto-oncogene 1, transcription factor | Heel vaak (80–99%) | In 1 aandoening |
| FCGR2BFc gamma receptor IIb | Heel vaak (80–99%) | In 1 aandoening |
| FCGR3BFc gamma receptor IIIb | Heel vaak (80–99%) | In 1 aandoening |
| GBA1glucosylceramidase beta 1 | Heel vaak (80–99%) | In 1 aandoening |
| HLA-Bmajor histocompatibility complex, class I, B | Heel vaak (80–99%) | In 3 aandoeningen |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Heel vaak (80–99%) | In 3 aandoeningen |
| HLCSholocarboxylase synthetase | Heel vaak (80–99%) | In 1 aandoening |
| IGHG1immunoglobulin heavy constant gamma 1 (G1m marker) | Heel vaak (80–99%) | In 1 aandoening |
| IL10interleukin 10 | Heel vaak (80–99%) | In 2 aandoeningen |
| IRAK1interleukin 1 receptor associated kinase 1 | Heel vaak (80–99%) | In 1 aandoening |
| IRF4interferon regulatory factor 4 | Heel vaak (80–99%) | In 1 aandoening |
| IRF5interferon regulatory factor 5 | Heel vaak (80–99%) | In 1 aandoening |
| ITGAMintegrin subunit alpha M | Heel vaak (80–99%) | In 1 aandoening |
| JAZF1JAZF zinc finger 1 | Heel vaak (80–99%) | In 1 aandoening |
| KIAA0319LKIAA0319 like | Heel vaak (80–99%) | In 1 aandoening |
| KRASKRas proto-oncogene, GTPase | Heel vaak (80–99%) | In 1 aandoening |
| MECP2methyl-CpG binding protein 2 | Heel vaak (80–99%) | In 2 aandoeningen |
| MMADHCmetabolism of cobalamin associated D | Heel vaak (80–99%) | In 1 aandoening |
| MMUTmethylmalonyl-CoA mutase | Heel vaak (80–99%) | In 1 aandoening |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Heel vaak (80–99%) | In 1 aandoening |
| PALB2partner and localizer of BRCA2 | Heel vaak (80–99%) | In 1 aandoening |
| PALLDpalladin, cytoskeletal associated protein | Heel vaak (80–99%) | In 1 aandoening |
| PDCD1programmed cell death 1 | Heel vaak (80–99%) | In 1 aandoening |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Heel vaak (80–99%) | In 2 aandoeningen |
| PXKPX domain containing serine/threonine kinase like | Heel vaak (80–99%) | In 1 aandoening |
| RABL3RAB, member of RAS oncogene family like 3 | Heel vaak (80–99%) | In 1 aandoening |
Toon nog 92 genen
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| SCARB2scavenger receptor class B member 2 | Heel vaak (80–99%) | In 1 aandoening |
| SLC19A2solute carrier family 19 member 2 | Heel vaak (80–99%) | In 1 aandoening |
| SLC46A1solute carrier family 46 member 1 | Heel vaak (80–99%) | In 1 aandoening |
| SMAD4SMAD family member 4 | Heel vaak (80–99%) | In 1 aandoening |
| SPP1secreted phosphoprotein 1 | Heel vaak (80–99%) | In 1 aandoening |
| STAT4signal transducer and activator of transcription 4 | Heel vaak (80–99%) | In 2 aandoeningen |
| TLR7toll like receptor 7 | Heel vaak (80–99%) | In 1 aandoening |
| TNFAIP3TNF alpha induced protein 3 | Heel vaak (80–99%) | In 1 aandoening |
| TNFSF4TNF superfamily member 4 | Heel vaak (80–99%) | In 1 aandoening |
| TNIP1TNFAIP3 interacting protein 1 | Heel vaak (80–99%) | In 1 aandoening |
| TP53tumor protein p53 | Heel vaak (80–99%) | In 1 aandoening |
| TREX1three prime repair exonuclease 1 | Heel vaak (80–99%) | In 1 aandoening |
| UBE2L3ubiquitin conjugating enzyme E2 L3 | Heel vaak (80–99%) | In 1 aandoening |
| AQP2aquaporin 2 | Vaak (30–79%) | In 1 aandoening |
| ASXL1ASXL transcriptional regulator 1 | Vaak (30–79%) | In 1 aandoening |
| ATMATM serine/threonine kinase | Vaak (30–79%) | In 1 aandoening |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Vaak (30–79%) | In 1 aandoening |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Vaak (30–79%) | In 1 aandoening |
| ATRXATRX chromatin remodeler | Vaak (30–79%) | In 1 aandoening |
| AVPR2arginine vasopressin receptor 2 | Vaak (30–79%) | In 1 aandoening |
| BCORBCL6 corepressor | Vaak (30–79%) | In 1 aandoening |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Vaak (30–79%) | In 1 aandoening |
| CBLCbl proto-oncogene | Vaak (30–79%) | In 1 aandoening |
| CCND1cyclin D1 | Vaak (30–79%) | In 1 aandoening |
| FIP1L1factor interacting with PAPOLA and CPSF1 | Vaak (30–79%) | In 1 aandoening |
| GLAgalactosidase alpha | Vaak (30–79%) | In 1 aandoening |
| HMGCL3-hydroxy-3-methylglutaryl-CoA lyase | Vaak (30–79%) | In 1 aandoening |
| IGHimmunoglobulin heavy locus | Vaak (30–79%) | In 1 aandoening |
| IL12Binterleukin 12B | Vaak (30–79%) | In 1 aandoening |
| IRF2BP2interferon regulatory factor 2 binding protein 2 | Vaak (30–79%) | In 1 aandoening |
| MC2Rmelanocortin 2 receptor | Vaak (30–79%) | In 1 aandoening |
| MLXMAX dimerization protein MLX | Vaak (30–79%) | In 1 aandoening |
| MRAPmelanocortin 2 receptor accessory protein | Vaak (30–79%) | In 1 aandoening |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Vaak (30–79%) | In 1 aandoening |
| NABP1nucleic acid binding protein 1 | Vaak (30–79%) | In 1 aandoening |
| NAGSN-acetylglutamate synthase | Vaak (30–79%) | In 1 aandoening |
| NNTnicotinamide nucleotide transhydrogenase | Vaak (30–79%) | In 1 aandoening |
| NPM1nucleophosmin 1 | Vaak (30–79%) | In 1 aandoening |
| NUMA1nuclear mitotic apparatus protein 1 | Vaak (30–79%) | In 1 aandoening |
| OTCornithine transcarbamylase | Vaak (30–79%) | In 1 aandoening |
| PMLPML nuclear body scaffold | Vaak (30–79%) | In 1 aandoening |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Vaak (30–79%) | In 1 aandoening |
| RARAretinoic acid receptor alpha | Vaak (30–79%) | In 1 aandoening |
| RHOBTB2Rho related BTB domain containing 2 | Vaak (30–79%) | In 1 aandoening |
| RUNX1RUNX family transcription factor 1 | Vaak (30–79%) | In 1 aandoening |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Vaak (30–79%) | In 1 aandoening |
| SLC1A3solute carrier family 1 member 3 | Vaak (30–79%) | In 1 aandoening |
| SLC2A1solute carrier family 2 member 1 | Vaak (30–79%) | In 1 aandoening |
| SRSF2serine and arginine rich splicing factor 2 | Vaak (30–79%) | In 1 aandoening |
| STARsteroidogenic acute regulatory protein | Vaak (30–79%) | In 1 aandoening |
| STAT3signal transducer and activator of transcription 3 | Vaak (30–79%) | In 1 aandoening |
| STAT5Bsignal transducer and activator of transcription 5B | Vaak (30–79%) | In 1 aandoening |
| TBL1XR1TBL1X/Y related 1 | Vaak (30–79%) | In 1 aandoening |
| TET2tet methylcytosine dioxygenase 2 | Vaak (30–79%) | In 2 aandoeningen |
| TXNRD2thioredoxin reductase 2 | Vaak (30–79%) | In 1 aandoening |
| ZBTB16zinc finger and BTB domain containing 16 | Vaak (30–79%) | In 1 aandoening |
| ACAT1acetyl-CoA acetyltransferase 1 | Soms (5–29%) | In 1 aandoening |
| CALRcalreticulin | Soms (5–29%) | In 1 aandoening |
| CBScystathionine beta-synthase | Soms (5–29%) | In 1 aandoening |
| CCR1C-C motif chemokine receptor 1 | Soms (5–29%) | In 1 aandoening |
| CD247CD247 molecule | Soms (5–29%) | In 1 aandoening |
| CD3DCD3 delta subunit of T-cell receptor complex | Soms (5–29%) | In 1 aandoening |
| CD3ECD3 epsilon subunit of T-cell receptor complex | Soms (5–29%) | In 1 aandoening |
| CDKN1Bcyclin dependent kinase inhibitor 1B | Soms (5–29%) | In 1 aandoening |
| CDKN2Bcyclin dependent kinase inhibitor 2B | Soms (5–29%) | In 1 aandoening |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Soms (5–29%) | In 1 aandoening |
| FASFas cell surface death receptor | Soms (5–29%) | In 1 aandoening |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Soms (5–29%) | In 1 aandoening |
| IFNGR1interferon gamma receptor 1 | Soms (5–29%) | In 2 aandoeningen |
| IL12Ainterleukin 12A | Soms (5–29%) | In 1 aandoening |
| IL12A-AS1IL12A antisense RNA 1 | Soms (5–29%) | In 1 aandoening |
| IL23Rinterleukin 23 receptor | Soms (5–29%) | In 1 aandoening |
| JAK2Janus kinase 2 | Soms (5–29%) | In 1 aandoening |
| KLRC4killer cell lectin like receptor C4 | Soms (5–29%) | In 1 aandoening |
| MEFVMEFV innate immunity regulator, pyrin | Soms (5–29%) | In 1 aandoening |
| MEN1menin 1 | Soms (5–29%) | In 1 aandoening |
| MPLMPL proto-oncogene, thrombopoietin receptor | Soms (5–29%) | In 1 aandoening |
| MYD88MYD88 innate immune signal transduction adaptor | Soms (5–29%) | In 1 aandoening |
| PKHD1PKHD1 ciliary IPT domain containing fibrocystin/polyductin | Soms (5–29%) | In 1 aandoening |
| PTPN3protein tyrosine phosphatase non-receptor type 3 | Soms (5–29%) | In 1 aandoening |
| ROS1ROS proto-oncogene 1, receptor tyrosine kinase | Soms (5–29%) | In 1 aandoening |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Soms (5–29%) | In 1 aandoening |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Soms (5–29%) | In 1 aandoening |
| SDHCsuccinate dehydrogenase complex subunit C | Soms (5–29%) | In 1 aandoening |
| SLC39A4solute carrier family 39 member 4 | Soms (5–29%) | In 1 aandoening |
| SYKspleen associated tyrosine kinase | Soms (5–29%) | In 1 aandoening |
| TGFB1transforming growth factor beta 1 | Soms (5–29%) | In 1 aandoening |
| TLR4toll like receptor 4 | Soms (5–29%) | In 1 aandoening |
| UBAC2UBA domain containing 2 | Soms (5–29%) | In 1 aandoening |
| ALPLalkaline phosphatase, biomineralization associated | Niet vastgelegd | In 1 aandoening |
| ARG1arginase 1 | Niet vastgelegd | In 1 aandoening |
| SLC4A1solute carrier family 4 member 1 (Diego blood group) | Niet vastgelegd | In 1 aandoening |
Hoe vaak dit voorkomt bij mensen met een van de aandoeningen van het gen, de hoogste frequentie binnen die aandoeningen, zoals de Human Phenotype Ontology dit vastlegt. Deze pagina's beschrijven kenmerken en het onderzoek erachter; het zijn geen diagnose, en over symptomen kunt u het best een arts of genetisch adviseur raadplegen.
Bredere kenmerken
Waar dit vandaan komt
- De Human Phenotype Ontology, release 2026-09-01: het kenmerk, de namen, de definitie en de genen die ermee verbonden zijn. Meer informatie vindt u op hpo.jax.org.
- Gegevensrelease 2026.10.16-c6eea6bf.
Eén test. Een leven lang antwoorden.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken